European Biosimilars Can Benefit From Sharing Experiences

Policy Solutions Discussed At Medicines For Europe Virtual Summit

 
• By Dave Wallace

Attendees to Medicines for Europe’s virtual summit on biosimilars heard how learning from experiences across Europe can allow individual countries to build a toolbox of policies to help create a sustainable biosimilars market.

Europe connections space
European countries can benefit from sharing experiences on biosimilars • Source: Alamy

More from Biosimilars

More from Products